Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-026386
Filing Date
2022-07-19
Accepted
2022-07-19 21:05:15
Documents
1
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4096
  Complete submission text file 0000899243-22-026386.txt   5526
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Issuer) CIK: 0001403752 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 114 EAST 4TH AVENUE, SUITE 800 VANCOUVER A1 V5T 1G4
Business Address
Moore Paul Andrew (Reporting) CIK: 0001938192 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38068 | Film No.: 221092625